Live Breaking News & Updates on Yutaka niihara

Stay informed with the latest breaking news from Yutaka niihara on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Yutaka niihara and stay connected to the pulse of your community

Doctors Daar, Niihara honored by The Lundquist Institute

by Elka Worner When two Lundquist Institute doctors began their research into HIV and sickle cell disease, getting an HIV diagnosis was a death sentence and…

United-states , India , Americans , Yutaka-niihara , Juanita-gougis , Albert-schweitzer , Eric-daar , Sickle-cell-foundation , Lundquist-institute-max-benavidez , Lundquist-institute , South-central , Middle-east

Emmaus Life Sciences aims to boost sales of sickle cell treatment amid leadership change

Emmaus Life Sciences Inc (OTCQX:EMMA) said Dr. Yutaka Niihara will no longer serve as the company’s CEO as Dr. Niihara pursues business opportunities in...

India , Japan , Willis-lee , Yutaka-niihara , George-sekulich , Drug-administration , Emmaus-life-sciences-inc , Middle-east-north-africa ,

Emmaus Life Sciences : Reports Q2 2023 Financial Results

Emmaus Life Sciences Reports Q2 2023 Financial Results

Record Net Revenues Contributed to Income from Operations

Sixth Straight Quarterly Increase in Net...
-Today at 03:28 pm- MarketScreener

France , Kuwait , Bahrain , United-arab-emirates , United-states , Saudi-arabia , Oman , Netherlands , Qatar , Israel , Americans , Kingdom-of-saudi-arabia

Emmaus Life Sciences Reports Q2 2023 Financial Results

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...

Kuwait , Oman , Saudi-arabia , France , United-states , Qatar , Bahrain , Israel , United-arab-emirates , Netherlands , Americans , Kingdom-of-saudi-arabia

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, today announced that it has received marketing...

France , United-arab-emirates , United-states , Oman , Bahrain , Saudi-arabia , Netherlands , Israel , Qatar , Kuwait , Kingdom-of-saudi-arabia , Omanis

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman - Emmaus Life Sciences (OTC:EMMA)

Sickle Cell Disease Treatment Commercially Available in Five GCC Countries TORRANCE, Calif., July 13, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a leader in sickle cell disease treatment, today

Israel , Saudi-arabia , Bahrain , Qatar , United-arab-emirates , United-states , Oman , Netherlands , Kuwait , France , Omani , Omanis

Emmaus Life Sciences receives approval to market Endari in Oman

Emmaus Life Sciences Inc (OTCQX:EMMA) announced that it has received marketing authorization from the Ministry of Health in Oman for the commercial...

Ministry-of-health , Masqat , Oman , United-arab-emirates , Qatar , Bahrain , Saudi-arabia , Israel , France , Kuwait , Netherlands , Omanis

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, today announced that it has received marketing authorization from the Oman Ministry of Health for the commercial distribution and sale of Endari® (L-glutamine oral powder) in the country to treat sickle cell disease in patients five years of age and older.

Qatar , United-states , Netherlands , Bahrain , Saudi-arabia , France , Israel , Kuwait , United-arab-emirates , Oman , Omani , Americans

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

Sickle Cell Disease Treatment Commercially Available in Five GCC Countries
TORRANCE, Calif., July 13, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment,...

Oman , Kuwait , Israel , United-arab-emirates , Saudi-arabia , Bahrain , Qatar , Netherlands , United-states , France , Omanis , Kingdom-of-saudi-arabia

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bahrain , Qatar , Israel , United-arab-emirates , Kuwait , India , Saudi-arabia , United-states , Americans , Kingdom-of-bahrain , Saudi , Kingdom-of-saudi-arabia